Viewing Study NCT04671251


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2025-12-28 @ 4:31 PM
Study NCT ID: NCT04671251
Status: COMPLETED
Last Update Posted: 2024-02-29
First Post: 2020-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor: Avalo Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module